Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Trimbow EU/1/17/1208/004 |
Glycopyrronium bromide, Formoterol fumarate dihydrate, Beclometasone dipropionate | Chiesi Farmaceutici S.p.A. | — |
| Trimbow EU/1/17/1208/005 |
Beclometasone dipropionate, Glycopyrronium bromide, Formoterol fumarate dihydrate | Chiesi Farmaceutici S.p.A. | — |
| Trimbow 172 micrograms/5 micrograms/9 micrograms pressurised inhalation, solution EU/1/17/1208/006-009 |
Beclometasone dipropionate, Formoterol fumarate dihydrate, Glycopyrronium bromide | Chiesi Farmaceutici S.p.A. | — |
| Trimbow 87 micrograms/5 micrograms/9 micrograms pressurised inhalation, solution EU/1/17/1208/001-003 |
Beclometasone dipropionate, Formoterol fumarate dihydrate, Glycopyrronium bromide | Chiesi Farmaceutici S.p.A. | — |
| Trimbow 88 micrograms/5 micrograms/9 micrograms inhalation powder EU/1/17/1208/010-012 |
Beclometasone dipropionate, Formoterol fumarate dihydrate, GLYCOPYRRONIUM, Glycopyrronium bromide | Chiesi Farmaceutici S.p.A. | — |
| Trimega 1000 mg Capsules PA0126/236/001 |
Omega-3-acid ethyl esters 90 | Clonmel Healthcare Ltd | Marketed |
| Trimethoprim 10 mg/ml Oral Suspension PA1418/005/001 |
Trimethoprim | Athlone Pharmaceuticals Limited | Not marketed |
| Trimoptin Tablets 100 mg PA1418/008/001 |
Trimethoprim | Athlone Pharmaceuticals Limited | Marketed |
| Trimoptin Tablets 200 mg PA1418/008/002 |
Trimethoprim | Athlone Pharmaceuticals Limited | Marketed |
| Trinomia 100 mg/20 mg/10 mg hard capsules PA1744/002/003 |
Acetylsalicylic acid, Ramipril, Atorvastatin calcium trihydrate | Ferrer Internacional, S.A | Marketed |
| Trinomia 100 mg/20 mg/2.5 mg hard capsules PA1744/002/001 |
Acetylsalicylic acid, Ramipril, Atorvastatin calcium trihydrate | Ferrer Internacional, S.A | Marketed |
| Trinomia 100 mg/20 mg/5 mg hard capsules PA1744/002/002 |
Acetylsalicylic acid, Ramipril, Atorvastatin calcium trihydrate | Ferrer Internacional, S.A | Marketed |
| Trinomia 100 mg/40 mg/10 mg hard capsules PA1744/002/006 |
Acetylsalicylic acid, Ramipril, Atorvastatin calcium trihydrate | Ferrer Internacional, S.A | Marketed |
| Trinomia 100 mg/40 mg/2.5 mg hard capsules PA1744/002/004 |
Acetylsalicylic acid, Ramipril, Atorvastatin | Ferrer Internacional, S.A | Marketed |
| Trinomia 100 mg/40 mg/5 mg hard capsules PA1744/002/005 |
Acetylsalicylic acid, Ramipril, Atorvastatin calcium trihydrate | Ferrer Internacional, S.A | Marketed |
| TRIOMEL 12 g/l nitrogen 950 kcal/l with electrolytes, emulsion for infusion PA2299/043/007 |
Alanine, Arginine, Aspartic Acid, Glutamic acid, Glycine | Baxter Holding B.V. | Marketed |
| TRIOMEL 12 g/l nitrogen 950 kcal/l, emulsion for infusion PA2299/043/008 |
Alanine, Arginine, Aspartic Acid, Glutamic acid, Glycine | Baxter Holding B.V. | Marketed |
| Triomel 5g/L nitrogen 990kcal/L with electrolytes, emulsion for infusion PA2299/029/002 |
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid | Baxter Holding B.V. | Marketed |
| Triomel 7g/L nitrogen 1140kcal/L emulsion for infusion PA2299/029/004 |
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid | Baxter Holding B.V. | Marketed |
| Triomel 7g/L nitrogen 1140kcal/L with electrolytes emulsion for infusion PA2299/029/003 |
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid | Baxter Holding B.V. | Marketed |
| Triomel 9g/L nitrogen 1070kcal/L emulsion for infusion PA2299/029/006 |
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid | Baxter Holding B.V. | Marketed |
| Triomel 9g/L nitrogen 1070kcal/L with electrolytes emulsion for infusion PA2299/029/005 |
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid | Baxter Holding B.V. | Marketed |
| Triomel Peripheral 4 g/L nitrogen 700 kcal/L with electrolytes emulsion for infusion PA2299/029/001 |
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid | Baxter Holding B.V. | Marketed |
| Triregol coated tablets PA1330/016/001 |
Ethinyloestradiol, Levonorgestrel, Levonorgestrel, Ethinylestradiol, Levonorgestrel | Gedeon Richter Plc | Not marketed |
| Trisenox EU/1/02/204/001 |
Arsenic trioxide | Teva B.V. | — |
| Trisenox 2 mg/ml concentrate for solution for infusion EU/1/02/204/002 |
Arsenic trioxide | Teva B.V. | — |
| Trisequens film-coated tablets PA0218/008/001 |
Estradiol, Estradiol, Norethisterone acetate, Estradiol | Novo Nordisk A/S | Marketed |
| TRITACE 1.25 mg Tablets PA0540/084/005 |
Ramipril | Sanofi-Aventis Ireland Limited T/A SANOFI | Not marketed |
| Tritace 10 mg Tablets PA0540/084/008 |
Ramipril | Sanofi-Aventis Ireland Limited T/A SANOFI | Marketed |
| Tritace 2.5 mg Tablets PA0540/084/006 |
Ramipril | Sanofi-Aventis Ireland Limited T/A SANOFI | Marketed |
| Tritace 5 mg Tablets PA0540/084/007 |
Ramipril | Sanofi-Aventis Ireland Limited T/A SANOFI | Marketed |
| Triumeq 5 mg/60 mg/30 mg dispersible tablets EU/1/14/940/001-003 |
Dolutegravir sodium, Lamivudine, Abacavir sulfate | ViiV Healthcare BV | — |
| Triumeq 50 mg/600 mg/300 mg film-coated tablets EU/1/14/940/001-002 |
Dolutegravir, Abacavir, Lamivudine | ViiV Healthcare BV | — |
| Trixeo Aerosphere 5/7.2/160 micrograms pressurised inhalation, suspension EU/1/20/1498/002-003 |
Budesonide micronised, Glycopyrronium bromide, Formoterol fumarate dihydrate (micronised) | AstraZeneca AB | — |
| Trizivir 300 mg/150 mg/300 mg film-coated tablets EU/1/00/156/002 |
Abacavir sulfate, Zidovudine, Lamivudine | ViiV Healthcare BV | — |
| Trizivir 300 mg/150 mg/300 mg film-coated tablets EU/1/00/156/003-4 |
Abacavir sulfate, Zidovudine, Lamivudine | ViiV Healthcare BV | — |
| Trodelvy 200 mg powder for concentrate for solution for infusion EU/1/21/1592/001 |
Sacituzumab Govitecan | Gilead Sciences Ireland UC | — |
| Tropex 5% w/v Ear Drops Solution PA0074/002/001 |
Phenazone | Rowa Pharmaceuticals Limited, | Marketed |
| Trosyl 283 mg/ml Nail Solution PA0822/197/001 |
Tioconazole | Pfizer Healthcare Ireland Unlimited Company | Marketed |
| Trosyl 283 mg/ml Nail Solution PPA0465/247/001 |
Tioconazole | PCO Manufacturing Ltd. | — |
| Trosyl 283 mg/ml Nail Solution PPA1463/169/001 |
Tioconazole | IMED Healthcare Ltd., | — |
| Trulicity 0.75 mg Solution for injection EU/1/14/956/001-005 |
Dulaglutide | Eli Lilly Nederland B.V. | — |
| Trulicity 1.5 mg Solution for injection EU/1/14/956/006-010 |
Dulaglutide | Eli Lilly Nederland B.V. | — |
| Trulicity 3 mg Solution for injection EU/1/14/956/011-0013 |
Dulaglutide | Eli Lilly Nederland B.V. | — |
| Trulicity 4.5 mg Solution for injection EU/1/14/956/014-0016 |
Dulaglutide | Eli Lilly Nederland B.V. | — |
| Trumenba suspension for injection in pre-filled syringe. Meningococcal group B vaccine (recombinant, adsorbed). EU/1/17/1187/001-006 |
Neisseria meningitidis serogroup b recombinant lipoprotein (rlp2086; sub family a), Neisseria meningitidis serogroup b recombinant lipoprotein (rlp2086; sub family b) | Pfizer Europe MA EEIG | — |
| Truoxin I.V. 200mg/100ml solution for infusion PA1217/002/001 |
Ciprofloxacin | Hikma Farmacêutica (Portugal) S.A. | Marketed |
| Truoxin I.V. 400 mg/200 ml solution for infusion PA1217/002/002 |
Ciprofloxacin | Hikma Farmacêutica (Portugal) S.A. | Marketed |
| TRUQAP 160 mg film-coated tablets EU/1/24/1820/001 |
Capivasertib | AstraZeneca AB | — |
| TRUQAP 200 mg film-coated tablets EU/1/24/1820/002 |
Capivasertib | AstraZeneca AB | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 16 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.